Skip to main content
. 2015 Jan 9;5:7705. doi: 10.1038/srep07705

Figure 2. PAM reduced CNV volume in vivo.

Figure 2

(A) The volume of laser-CNV in 1.0 μL PAM-injected eyes was reduced by 33% (P = 0.0035) and 2.0 μL PAM-injected eyes was reduced by 36% (P = 0.0049) compared with that in control (Ctrl) eyes. (B, C) Representative images of laser-CNV in control eye (B) and 1 μL PAM-injected eyes (C). Scale bar = 50 μm, **P < 0.01.

HHS Vulnerability Disclosure